The British Journal of Psychiatry · 2003 · 865 citations · 21 references
MedicineGeriatric MedicinePsychologyDementiaGeriatric PsychiatryPsychotherapyCognitive Behavioral TherapyCognitive ImpairmentCognitive RehabilitationDementia CareDementia RehabilitationDementia TreatmentControl Group DesignMatched Control GroupMental State ExaminationMulti-center TrialsOutcome Measures
A recent Cochrane review highlighted the need for large, well‑designed, multi‑centre trials of reality orientation therapy in dementia. The study aimed to test whether cognitive stimulation therapy improves cognition and quality of life in older adults with dementia. A single‑blind, multi‑centre RCT enrolled 201 participants, comparing CST to control with intention‑to‑treat ANCOVA on cognitive function and quality‑of‑life outcomes. CST produced significant gains in MMSE, ADAS‑Cog, and QoL versus control (P = 0.044, 0.014, 0.028), with a number‑needed‑to‑treat of six, and its benefits were comparable to pharmacological trials.
Background A recent Cochrane review of reality orientation therapy identified the need for large, well-designed, multi-centre trials. Aims To test the hypothesis that cognitive stimulation therapy (CST) for older people with dementia would benefit cognition and quality of life. Method A single-blind, multi-centre, randomised controlled trial recruited 201 older people with dementia. The main outcome measures were change in cognitive function and quality of life. An intention-to-treat analysis used analysis of covariance to control for potential variability in baseline measures. Results One hundred and fifteen people were randomised within centres to the intervention group and 86 to the control group. At follow-up the intervention group had significantly improved relative to the control group on the Mini-Mental State Examination ( P =0.044), the Alzheimer's Disease Assessment Scale – Cognition (ADAS–Cog) ( P =0.014) and Quality of Life – Alzheimer's Disease scales ( P =0.028). Using criteria of 4 points or more improvement on the ADAS–Cog the number needed to treat was 6 for the intervention group. Conclusion The results compare favourably with trials of drugs for dementia. CST groups may have worthwhile benefits for many people with dementia.
21
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
A New Clinical Scale for the Staging of Dementia
Charles P. Hughes, Leonard van den Berg, Warren L. Danziger et al. · The British Journal of Psychiatry · 1982 · 7K citations
A new rating scale for Alzheimer's disease
Wilma G. Rosen, Richard C. Mohs, Kenneth L. Davis · American Journal of Psychiatry · 1984 · 4.2K citations
Cornell scale for depression in dementia
George S. Alexopoulos, Robert C. Abrams, Robert C. Young et al. · Biological Psychiatry · 1988 · 2.7K citations
Medicine, Psychiatry, Psychology +14